Medidata Solutions, Inc. (MDSO)
(Delayed Data from NSDQ)
$93.97 USD
+1.49 (1.61%)
Updated May 3, 2019 04:00 PM ET
After-Market: $93.97 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$93.97 USD
+1.49 (1.61%)
Updated May 3, 2019 04:00 PM ET
After-Market: $93.97 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Medidata Solutions (MDSO) Earnings Expected to Grow: What to Know Ahead of Q3 Release
by Zacks Equity Research
Medidata (MDSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medidata (MDSO) Collaborates With Mapi Research to Boost Rave
by Zacks Equity Research
Medidata's (MDSO) latest collaboration is expected to solve major eCOA implementation struggles in the pharmaceutical industry.
Medidata (MDSO) Up 0.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Medidata (MDSO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Medidata (MDSO) Earnings and Revenues Beat Estimates in Q2
by Zacks Equity Research
Medidata (MDSO) gains from solid segmental contributions in Q2.
Earnings Preview: Medidata Solutions (MDSO) Q2 Earnings Expected to Decline
by Zacks Equity Research
Medidata (MDSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stock Market News For Jun 14, 2019
by Zacks Equity Research
Markets closed in the green on Thursday after energy shares rallied following an attack on oil tankers in the Gulf of Oman.
Medidata (MDSO) to be Acquired by Dassault for $5.8 Billion
by Zacks Equity Research
Dassault's acquisition of Medidata (MDSO) to close by 2019-end.
Here's Why You Should Hold on to Medidata (MDSO) Stock Now
by Zacks Equity Research
Medidata Solutions (MDSO) continues to benefit from solid R&D focus, Rave Genomics platform and cloud-based services. However, stiff competition remains a concern.
Medidata (MDSO) Down 1.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Medidata (MDSO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Medidata (MDSO) Q1 Earnings Beat Estimates, Margins fall
by Zacks Equity Research
Medidata (MDSO) witnesses year-over-year revenue growth in double-digits across both operating segments in first-quarter 2019.
Will Flagship Impella Drive ABIOMED's (ABMD) Q4 Earnings?
by Zacks Equity Research
ABIOMED's (ABMD) fourth-quarter results are likely to gain from flagship Impella despite foreign exchange headwinds.
Why the Earnings Surprise Streak Could Continue for Medidata (MDSO)
by Zacks Equity Research
Medidata (MDSO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
DexCom (DXCM) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
DexCom's (DXCM) G6 censors and lucrative collaborations are likely to drive Q1 results.
Medidata Solutions (MDSO) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Medidata (MDSO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BioTelemetry (BEAT) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Products like MCT and Ware Holter are likely to aid BioTelemetry (BEAT) in Q1.
Cerner (CERN) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Top-line growth and solid show by Population Health, Revenue Cycle and IT Works are likely to aid Cerner (CERN) in Q1. However, expected decline in bookings is likely to be a dampener.
Can Diagnostic Revenues Fuel PerkinElmer's (PKI) Q1 Earnings?
by Zacks Equity Research
Strength in PerkinElmer's (PKI) core Diagnostics business is expected to drive Q1 results amid foreign exchange woes.
Bright Near-Term Outlook for Medical Info Systems Industry
by Sweta Jaiswal
The wave of digital transition is helping players in the Zacks Medical Info Systems industry to open up bountiful opportunities for investors.
Medidata Launches Acorn Artificial Intelligence Company
by Zacks Equity Research
Driven by Medidata's (MDSO) standardized clinical data storehouse, and operating on its pioneering platform, Acorn AI is set to become one of the premier AI companies in the field of life sciences.
Medidata (MDSO) Surges: Stock Moves 7.5% Higher
by Zacks Equity Research
Medidata (MDSO) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Earnings Preview: Medidata Solutions (MDSO) Q1 Earnings Expected to Decline
by Zacks Equity Research
Medidata (MDSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Medidata (MDSO) Up 3.4% Since Last Earnings Report?
by Zacks Equity Research
Medidata (MDSO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Medidata's (MDSO) Margins Under Pressure, Competition Rife
by Zacks Equity Research
Medidata (MDSO) suffers from cutthroat competition in the clinical trial solutions market at the moment.
Medidata (MDSO) Q4 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
Medidata (MDSO) gains from solid segmental performance in Q4.
Medidata Solutions (MDSO) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Medidata (MDSO) delivered earnings and revenue surprises of 21.62% and -0.34%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?